logo
Unbuilt vision: Why Mumbai's eastern waterfront dream was so remarkable

Unbuilt vision: Why Mumbai's eastern waterfront dream was so remarkable

MUMBAI: Broad pavements, lush gardens and a low building footprint aren't features typically associated with Mumbai's urban sprawl. And, yet, a 28-km stretch along the eastern shoreline fringed by a 6.4-km-long promenade promised just that. Designed to give Mumbaiites one of the things they need most, breathing space, the plan envisioned spaces devoted to art, culture and entertainment, among other features rarely seen in this space-starved metropolis. Unbuilt vision: Why Mumbai's eastern waterfront dream was so remarkable
Finalised in 2018, this was the second plan for Mumbai's eastern shoreline, proposed to transform 966.30 hectares of land owned by the MbPA. It has now been virtually shelved by a third plan, one that will see 217 acres of MbPA land leased for industrial and commercial purposes, for up to 30 years. Tenders have been floated and, unlike the earlier two proposals, this one has begun to roll. HT was the first to report on the plan on August 12.
The first proposal for the eastern shoreline was submitted in 2014 by a committee headed by retired bureaucrat Rani Jadhav. It was set aside after it was opposed by citizens' groups. The 2018 plan, prepared by an Ahmedabad-based architectural firm called HCP, founded by Hasmukh C Patel and now led by Dr Bimal Patel, was prepared under the chairmanship of retired bureaucrat Sanjay Bhatia. It was meant to transform the Mumbai port area into a benchmark for port areas in other coastal cities in India.
The third, and current, plan envisages leasing 28 plots on a consolidated area of 217 acres, from Colaba to Wadala, in addition to one plot in Thal near Alibag. By leasing these plots for industrial and commercial purposes, MbPA intends to earn ₹814.04 crore in the first year, with an annual lease escalation of 2%.
The properties to be leased include a 22-hectare plot at Princess Dock near the domestic cruise terminal; a 1.2-lakh sq m plot that once housed an HPCL facility in Wadala; a 42,955-sq m plot that used to have warehouses of the Food Corporation of India in Wadala; the Sewri Timber Pond, a cargo storage yard measuring 1.04 lakh sq m near the Mumbai Trans Harbour Link; and various buildings owned by the MbPA along the city's east coast.
The plan has been criticised for its narrow vision, denying Mumbaiites a world-class waterfront they had been promised. The 2018 master plan included port and sea tourism facilities, with water transport facilities to ease the growing traffic issues of Mumbai. It included water taxis, roll on-roll off services, an international cruise terminal, a domestic cruise terminal, a seaplane service, a marina, a Sewri-Elephanta ropeway, an eco-trail within mangroves and mud flats to spot migratory birds, and a host of other facilities and public amenities.
Apart from tourism, commercial spaces, retail outlets, residential zones and the informal sector were also to be tapped. With South Mumbai having lost its position as the city's central business district, a portion of the port land was to have commercial spaces to claw back corporate offices and to house a government office complex.
Malls and shopping-themed streets similar to Colaba and Bandra's Linking Road were also pitched for retail space.
Residential real estate has been on the decline in the island city and headed towards the suburbs. The 2018 plan aimed to unlock land for residential purposes including staff quarters for government and public undertakings, and to rehabilitate slums.
The holistic eastern waterfront development plan included the informal sector, which plays a crucial role in Mumbai's economy. 'The MbPA proposal was to provide space and spatial instruments to facilitate the informal sector in a planned and desirable manner, not affecting other users of space in any negative way,' the 2018 proposal states. Demand-based vending zones and daily bazaars was part of the proposal.
Once these plans unfolded, the waterfront would accommodate a 2.7-lakh residential population. Unlike most urban areas, the port area would have had an unusually large floating population attracted by commercial, industrial, port operations, tourism and healthcare zones. An estimate for this was 4.9 lakh, according to the plan.
'This was a holistic plan. The idea was to utilise Floor Space Index of all the land parcels towards buildings and then have the remaining land for recreation. One of the plots that the MbPA now intends to lease is where a marina was proposed. I don't know why such a wonderful master plan has been shelved,' said one of the individuals who worked on the master plan.
The grand vision took shape after Nitin Gadkari was appointed ports minister when the NDA government came to power at the centre in 2014. Then, just a year after the proposal was submitted, Gadkari was divested of the ports ministry in a cabinet reshuffle in 2019, and the plan was put on the backburner.
'Both the 2018 master plan and the current one prioritise land monetisation for the port authority over the needs of the city. But the difference is that the 2018 plan had followed at least some public process, whereas this one is devoid of any public process,' said urban researcher and professor Hussain Indorewala.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aurobindo Pharma expects China plant to break even at Ebitda level in FY26
Aurobindo Pharma expects China plant to break even at Ebitda level in FY26

Business Standard

timean hour ago

  • Business Standard

Aurobindo Pharma expects China plant to break even at Ebitda level in FY26

Aurobindo Pharma expects its China facility to break even in the third quarter of the current financial year, according to its CFO Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of November 2024 and is now ramping up production. "This facility with an initial capacity of 2 billion units plus is ramping up as expected and will begin contributing to revenue in the coming quarters and is expected to break even at the Ebitda (earnings before interest, taxes, depreciation, and amortisation) level by Q3 FY26," Subramanian said in an analyst call. He noted that around $145 million has been invested in the facility, which commenced production and invoicing in Q4 FY25 and Q1 FY26, respectively. Elaborating on other investments, Subramanian said the company has invested about $70 million in two US facilities, with production expected to start in the current fiscal year. Elaborating further, he noted that the company plans to file for more than 20 products in the US and Europe from its Eugia-V plant in Visakhapatnam. He noted that the company has invested around $30 million in the Biologics CMO business so far, and the balance of $100 million plus capital is expected to be invested by March 2027. On business outlook, Subramanian stated: "Looking ahead, we remain optimistic about sustaining our growth momentum. Our confidence is supported by expected volume expansion, continued product launches and a stable pricing environment, especially in the US and Europe". Commercial operations ramping up at new manufacturing sites would further support the topline growth and margin improvement in the upcoming quarters, he added. "We are confident of achieving our internal target margin of 20-21 per cent in FY26," Subramanian stated. Aurobindo Pharma reported a 10 per cent year-on-year dip in its consolidated net profit to ₹824 crore for the June quarter, due to a fall in sales in the US and API business vertical. Its revenue from operations increased to ₹7,868 crore for the June quarter against ₹7,567 crore in the year-ago period.

Pakistan wants to earn billions with its 'rare earth treasure' while walking US-China tightrope
Pakistan wants to earn billions with its 'rare earth treasure' while walking US-China tightrope

Time of India

timean hour ago

  • Time of India

Pakistan wants to earn billions with its 'rare earth treasure' while walking US-China tightrope

Pakistan's Army Chief Asim Munir has said the country possesses a 'rare earth treasure' that could ease its debt burden and elevate it among prosperous nations, ANI reported citing Pakistan-based media. His remarks come at a time when rare earths have become central to global supply chain strategies, with China deploying them as a tool of economic leverage and the United States, India, and others scrambling to diversify access. In an interaction published by Jang media, Munir said, 'Pakistan has a rare earth treasure; with this treasure, Pakistan's debt will also be reduced, and Pakistan will soon be counted among the most prosperous societies.' by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Belly Fat Removal Without Surgery in Algeria: The Price Might Surprise You Belly Fat Removal | Search Ads Get Info He pointed specifically to the Reko Diq mining project in Balochistan, predicting that from next year Pakistan could earn at least $2 billion annually, with profits expected to rise year after year. China's dominance in rare earths as India in a tight spot China accounts for the bulk of global rare earth mining and nearly all refining capacity. Over the past year, Beijing has tightened export controls on minerals and high-performance magnets crucial for electric vehicles, defence systems and electronics. Live Events Also Read: Papum Pare to Singrauli- India maps fresh hotspots for rare earth metals amid China concerns In early 2025, it placed restrictions on shipments to the United States, forcing Washington into a temporary tariff truce. While some export curbs were relaxed, military-grade materials remain under control, leaving global industries wary. As for India, which imports over 70% of its rare earth requirements from China, has been exposed to these supply chain disruptions. Automakers such as Maruti Suzuki and Bajaj have reported hurdles in their EV plans, while electronics and machinery sectors have also faced pressure. Economists warn that prolonged shortages could ripple across multiple industries. To counter this, New Delhi is preparing a ₹5,000 crore scheme to ramp up domestic production and reduce dependence on Chinese imports. Against this backdrop, Munir is attempting to present Pakistan's mineral wealth as a strategic card. The U.S. factor The United States has stepped up efforts to secure alternative sources of critical minerals, viewing overreliance on China as a national security risk. Munir has visited the United States twice in the past few months for high-level engagements, underscoring a warmer phase in ties. On Pakistan's Independence Day, US Secretary of State Marco Rubio said Washington was keen to 'explore new areas of economic cooperation, including critical minerals and hydrocarbons.' His statement followed the announcement of a new trade agreement aimed at lowering tariffs and attracting US investment in Balochistan's mining projects. Also Read: US eyes critical minerals, hydrocarbons in fresh economic push with Pakistan Washington has also expanded energy cooperation with Islamabad, with Pakistan's largest refiner sealing a deal to import U.S. crude shipments as part of a wider oil deal. Furthermore, Trump has made overly optimistic claims about helping Pakistan to develop large oil reserves for potential exports. Last month, Donald Trump unveiled a 25% tariff on Indian imports while simultaneously announcing an oil partnership with Pakistan. 'We have just concluded a Deal with the Country of Pakistan, whereby Pakistan and the United States will work together on developing their massive Oil Reserves… Who knows, maybe they'll be selling Oil to India some day!' Trump wrote on Truth Social. These moves point to a broadening economic and strategic agenda between the two countries, where minerals could emerge as a new axis of cooperation. For Washington, Pakistan's rare earth potential is another incentive to deepen ties. The Washington Post earlier reported that US officials view Pakistan's untapped reserves as a hedge against Chinese dominance. However, for Munir & Pakistan government this will be an act of balancing global powers. Can Pakistan really make it happen? But Pakistan's strategic geography also ties it closely to Beijing. China is building a 2,000-mile transport network through northern Pakistan to a southern port, linking its Belt and Road Initiative to the Arabian Sea. At the same time, separatist violence in Balochistan, where Reko Diq is located, continues to target mining operations. The US recently designated the Balochistan Liberation Army (BLA) as a terrorist organisation, aligning with Islamabad's security concerns. Munir has publicly stated that Pakistan seeks equilibrium in its external relations. 'We will not sacrifice one friend for the other,' he was quoted as saying in Jang media, signalling a desire to balance ties with both the U.S. and China.

Aurobindo Pharma expects China plant to break even at EBITDA level this year
Aurobindo Pharma expects China plant to break even at EBITDA level this year

Mint

time2 hours ago

  • Mint

Aurobindo Pharma expects China plant to break even at EBITDA level this year

New Delhi, Aurobindo Pharma expects its China facility to break even in the third quarter of the current financial year, according to its CFO Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of November 2024 and is now ramping up production. "This facility with an initial capacity of 2 billion units plus is ramping up as expected and will begin contributing to revenue in the coming quarters and is expected to break even at the EBITDA level by Q3 FY26," Subramanian said in an analyst call. He noted that around USD 145 million has been invested in the facility, which commenced production and invoicing in Q4 FY25 and Q1 FY26, respectively. Elaborating on other investments, Subramanian said the company has invested about USD 70 million in two US facilities, with production expected to start in the current fiscal year. Elaborating further, he noted that the company plans to file for more than 20 products in the US and Europe from its Eugia-V plant in Visakhapatnam. He noted that the company has invested around USD 30 million in the Biologics CMO business so far, and the balance of USD 100 million plus capital is expected to be invested by March 2027. On business outlook, Subramanian stated: "Looking ahead, we remain optimistic about sustaining our growth momentum. Our confidence is supported by expected volume expansion, continued product launches and a stable pricing environment, especially in the US and Europe". Commercial operations ramping up at new manufacturing sites would further support the topline growth and margin improvement in the upcoming quarters, he added. "We are confident of achieving our internal target margin of 20-21 per cent in FY26," Subramanian stated. Aurobindo Pharma reported a 10 per cent year-on-year dip in its consolidated net profit to ₹ 824 crore for the June quarter, due to a fall in sales in the US and I business vertical. Its revenue from operations increased to ₹ 7,868 crore for the June quarter against ₹ 7,567 crore in the year-ago period. This article was generated from an automated news agency feed without modifications to text.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store